These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9774761)
1. Effects of oral and transdermal hormone replacement therapy on lipoprotein(A) and lipids: a randomized controlled trial. Meschia M; Bruschi F; Soma M; Amicarelli F; Paoletti R; Crosignani P Menopause; 1998; 5(3):157-62. PubMed ID: 9774761 [TBL] [Abstract][Full Text] [Related]
2. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Zegura B; Guzic-Salobir B; Sebestjen M; Keber I Menopause; 2006; 13(4):643-50. PubMed ID: 16837886 [TBL] [Abstract][Full Text] [Related]
3. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Vrablik M; Fait T; Kovar J; Poledne R; Ceska R Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534 [TBL] [Abstract][Full Text] [Related]
5. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Araújo DA; Farias ML; Andrade AT Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087 [TBL] [Abstract][Full Text] [Related]
6. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance. Erenus M; Karakoç B; Gürler A Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947 [TBL] [Abstract][Full Text] [Related]
7. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study. Hemelaar M; van der Mooren MJ; Mijatovic V; Bouman AA; Schijf CP; Kroeks MV; Franke HR; Kenemans P Menopause; 2003; 10(6):550-8. PubMed ID: 14627865 [TBL] [Abstract][Full Text] [Related]
8. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia. Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744 [TBL] [Abstract][Full Text] [Related]
9. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women. Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213 [TBL] [Abstract][Full Text] [Related]
10. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women. Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528 [TBL] [Abstract][Full Text] [Related]
11. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495 [TBL] [Abstract][Full Text] [Related]
12. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy. Ylikorkala O; Lim P; Caubel P Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559 [TBL] [Abstract][Full Text] [Related]
13. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate. Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134 [TBL] [Abstract][Full Text] [Related]
14. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol]. Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034 [TBL] [Abstract][Full Text] [Related]
15. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206 [TBL] [Abstract][Full Text] [Related]
16. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women]. Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849 [TBL] [Abstract][Full Text] [Related]
17. Effect of continuous combined estrogen and desogestrel hormone replacement therapy on serum lipids and lipoproteins. Marsh MS; Crook D; Whitcroft SI; Worthington M; Whitehead MI; Stevenson JC Obstet Gynecol; 1994 Jan; 83(1):19-23. PubMed ID: 8272301 [TBL] [Abstract][Full Text] [Related]
18. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy. Prázný M; Fait T; Vrablik M Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976 [TBL] [Abstract][Full Text] [Related]
19. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial. Falkeborn M; Lithell H; Persson I; Vessby B; Naessén T Climacteric; 2002 Sep; 5(3):240-8. PubMed ID: 12419082 [TBL] [Abstract][Full Text] [Related]
20. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women. Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]